Insider sale
DYNE THERAPEUTICS, INC.
$3.36M
162.95K shares
What this filing means
ATLAS VENTURE FUND XI, L.P. plans to sell 162.95K shares of DYNE THERAPEUTICS, INC. valued at approximately $3.36M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/26/2026ACC: 0001628280-26-045819
10% Owner
Since Sep 2020
162.95K
Shares to sell
$3.36M
Approx. market value
162.95K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Private Placement
Cash
7/31/2020
162.95KTotal acquired162.95K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/31/2020 | Private Placement Cash | 162.95K | — |
| Total | 162.95K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
162.95K
Market value
$3.36M
6/26/2026
Total
Units
162.95K
Value
$3.36M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/26/2026 | 162.95K | $3.36M | Nasdaq | Planned |
| Total | 162.95K | $3.36M | ||